Clearside Biomedical, Inc. Common Stock
Symbol: CLSD (NASDAQ)
0.34
▲ (3.04%) 0.010
Company Description:
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.
Key Stats
- Today's Open: $0.325
- Today's High: $0.342
- Today's Low: $0.325
- Today's Volume: 0
- Yesterday Close: $0.3319
- Yesterday High: $0.354
- Yesterday Low: $0.312
- Yesterday Volume: 1.13M
- Last Min Volume: 0
- Last Min High: $0.342
- Last Min Low: $0.325
- Last Min VWAP: $0
Company Profile
- Name: Clearside Biomedical, Inc. Common Stock
- Website: https://www.clearsidebio.com
- Listed Date: 2016-06-02
- Location: ALPHARETTA, GA
- Market Status: Active
- CIK Number: 0001539029
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $26.06M
- Round Lot: 100
- Outstanding Shares: 78.51M
- Asset Type: CS
RECENT FILINGS FOR CLSD
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-08 | 8-K | View |
| 2025-09-03 | 8-K | View |
| 2025-08-14 | 8-K | View |
| 2025-08-08 | 10-Q | View |
| 2025-08-04 | DEF 14A | View |
| 2025-07-25 | PRE 14A | View |
| 2025-07-17 | 8-K | View |
| 2025-05-30 | 8-K | View |
| 2025-05-15 | S-8 | View |
| 2025-05-15 | 10-Q | View |
| 2025-05-14 | 8-K | View |
| 2025-04-18 | ARS | View |
| 2025-04-18 | DEFA14A | View |
| 2025-04-18 | DEF 14A | View |
| 2025-04-08 | PRE 14A | View |
| 2025-04-01 | SCHEDULE 13G | View |
| 2025-03-27 | 10-K | View |
| 2025-03-27 | 8-K | View |
| 2025-03-04 | SCHEDULE 13G/A | View |
| 2025-02-24 | 4 | View |
Latest News on CLSD